Eli Lilly (NYSE:LLY | LLY Price Prediction) just delivered one of the most impressive quarters in big pharma history, and the stock is responding. After a sharp drawdown in early 2026, shares…
Vandita Jadeja Few stocks have polarized investors in 2026 like Eli Lilly (NYSE:LLY | LLY Price Prediction). After a stunning Q1 earnings report and raised full-year guidance, the question is whether the valuation has…
The market adage “Sell in May and Go Away” rarely fits a single name cleanly. Eli Lilly (NYSE: LLY | LLY Price Prediction) is an unusual exception this spring. The GLP-1 leader…
Trey Thoelcke Pfizer (NYSE: PFE | PFE Price Prediction) and Eli Lilly (NYSE: LLY) recently reported quarterly results that read like two scripts from opposite ends of pharma. Lilly posted 55.55% revenue growth from…
Investors are concerned about where the stock market is headed this year. While the S&P 500 has maintained upward momentum, the narrative has shifted toward significant sector dispersion. If you are worried…
Eli Lilly (NYSE:LLY | LLY Price Prediction) received another bullish call from Wall Street. Barclays analyst Emily Field raised her price target on Eli Lilly stock to $1,400 from $1,350 and reiterated…
The hosts of Morning Brew Daily made a simple argument on a recent episode that the idea of the “Ozempic economy” should be replaced with the “Mounjaro economy” now that Eli Lilly…
Eli Lilly (NYSE:LLY | LLY Price Prediction) just delivered one of the strongest first quarters in big pharma history, but shares have pulled back sharply from their February peak. That gap between…
Vandita Jadeja I keep buying Eli Lilly (NYSE:LLY | LLY Price Prediction), and the latest quarter just made it harder to stop. This is a confession of conviction. I have been adding through every…
Vandita Jadeja Growth investors picking a large-cap vehicle in 2026 face a real choice: pay nothing for a passive index, or pay a few basis points for an active manager who claims to add…
CNBC’s Fast Money panel recently made a notable pivot on its April 24 episode, arguing that Novo Nordisk (NYSE:NVO | NVO Price Prediction) now offers a more compelling setup than GLP-1 category…
The S&P 500 (^GSPC) is off to the races this morning, up 0.50% thanks to tailwinds from mega-cap earnings beats and a sharp pullback in oil prices, even as the Fed’s preferred…
Alex Karnal, co-founder and CIO of Braidwell, a life sciences investment firm, spent 20 years building and backing biotech companies before declaring on the Invest Like the Best podcast that “2025 was…
Live Updates Warsh on Fed Independence 12:39pm ETFed chair nominee Kevin Warsh in prepared remarks before the Senate Banking Committee said the central bank must remain largely independent of political influence while…
Eli Lilly and Company (NYSE:LLY | LLY Price Prediction) and Novo Nordisk A/S (NYSE:NVO) reported quarterly results in early February, and the gap between them has widened significantly. Lilly’s tirzepatide franchise is…
